Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-01-31

Clinical Trial Update: Pretreatment MRI Predicting Outcome After Radio-frequency Ablation of HCC

View source ↗

Summary

An update on a trial evaluating whether pretreatment MRI can predict outcomes after radio-frequency ablation in hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Hepatocellular Carcinoma | Status: UNKNOWN